L. Becker Hewes
CIK 1840110 · Chief Medical Officer · last filed 2026-01-07
L. Becker Hewes is a Chief Medical Officer who has filed 21 SEC Form 4 insider transactions across 2 companies since 2021. The most recent filing, for GLTO, was dated Jan 7, 2026. Across all open-market trades the lifetime net is −$7.7M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
21
-$7.70M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Damora Therapeutics, Inc. (GLTO) Delisted | Chief Medical Officer | 264,629 | $28.69 | $7.59M | $0 | 1 | 2026-01-07 |
| Blueprint Medicines Corp (BPMC) Delisted | Chief Medical Officer | 1,607 | $129.46 | $208.0K | -$7.70M | 20 | 2025-07-21 |
Recent Filings
21 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-07 | Damora Therapeutics, Inc. (GLTO) Delisted | Grant (A) | +264,629 | $0 | EDGAR |
| 2025-07-21 | Blueprint Medicines Corp (BPMC) Delisted | Mixed | −30,419 | $0 | EDGAR |
| 2025-03-07 | Blueprint Medicines Corp (BPMC) Delisted | Sell (S) | −10,095 | -$890.6K | EDGAR |
| 2025-03-04 | Blueprint Medicines Corp (BPMC) Delisted | Grant (A) | +11,000 | $0 | EDGAR |
| 2024-06-06 | Blueprint Medicines Corp (BPMC) Delisted | Sell (S) | −2,424 | -$254.3K | EDGAR |
| 2024-06-04 | Blueprint Medicines Corp (BPMC) Delisted | Mixed | −14,343 | -$2.67M | EDGAR |
| 2024-03-11 | Blueprint Medicines Corp (BPMC) Delisted | Sell (S) | −3,097 | -$280.9K | EDGAR |
| 2024-03-06 | Blueprint Medicines Corp (BPMC) Delisted | Grant (A) | +12,500 | $0 | EDGAR |
| 2023-06-07 | Blueprint Medicines Corp (BPMC) Delisted | Sell (S) | −1,404 | -$73.1K | EDGAR |
| 2023-03-08 | Blueprint Medicines Corp (BPMC) Delisted | Sell (S) | −1,514 | -$69.2K | EDGAR |